Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma
- PMID: 31345339
- DOI: 10.1016/j.jtho.2019.03.009
Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
